As per SNS Insider Research, North America Leads the Market with 48% Share, While Asia Pacific Emerges as the Fastest-Growing Region with Strong Investment Momentum.
Austin, Nov. 20, 2025 (GLOBE NEWSWIRE) — According to SNS Insider, the global Diabetic Ulcer Treatment Market was valued at USD 8.22 billion in 2023 and is projected to reach USD 14.35 billion by 2032, growing at a CAGR of 7.21% over the forecast period of 2024 to 2032. This growth is strongly influenced by the rising incidence of diabetic foot infections, increasing amputation rates, and the expanding adoption of advanced wound care solutions.
Get a Sample Report of Diabetic Ulcer Treatment Market Forecast: https://www.snsinsider.com/sample-request/3439
Foot ulcers remain one of the most serious and overlooked complications of diabetes. They affect an estimated 15% to 25% of diabetic patients during their lifetime. If left untreated, these ulcers can lead to severe infections, tissue damage, gangrene, and eventual limb amputation. Global statistics from the International Diabetes Federation reveal that more than 1 million diabetes-related amputations are performed every year. This trend increases the urgency for highly effective ulcer management and supports the demand for advanced treatments such as negative pressure wound therapy, antimicrobial dressings, and regenerative wound care technologies.
Governments and healthcare organizations worldwide are prioritizing early detection programs, strengthening reimbursement support, and establishing advanced wound care centers to reduce amputation rates. These developments are creating steady demand for innovation in diabetic ulcer treatment.
Major Players Analysis Listed in the Diabetic Ulcer Treatment Market Report Are:
- ConvaTec, Inc.
- 3M Healthcare
- Acelity L.P., Inc.
- Smith & Nephew Plc
- Coloplast Corp.
- B. Braun Melsungen AG
- Organogenesis, Inc.
- Mölnlycke Health Care AB
- Medline Industries, Inc.
- Medtronic
- Integra LifeSciences
- Cardinal Health
- Essity Aktiebolag
- SANUWAVE Health
- Centaur Pharmaceuticals
- Remedor Biomed
- Derma Sciences Inc.
- KCI Licensing, Inc.
- Alliqua Biomedical, Inc.
- MiMedx Group, Inc.
Segmentation Analysis:
By Type
Foot ulcers hold the largest market share around 72% in 2023 owing to the high prevalence among diabetic patients along with its serious health consequences. This segment is likely to continue holding the largest market share owing to the investments being made by governments and healthcare organizations to design tailor-made preventive care programs, diabetic foot screening programs, and patient education initiatives designed to minimize the occurrence of foot ulcers.
By Treatment
Wound care dressings held the largest market share around 48% in 2023 owing to the importance of the product in the treatment of diabetic foot ulcers, venous ulcers, and pressure ulcers. The increasing investment in advanced wound care products and technologies, such as bioactive and nanotechnology-based dressings, continued strategic government plans to prevent and manage diabetic foot ulcers are propelling the growth of the wound care dressings market.
By End Use Industry
Hospitals and clinics held the largest market share around 38% in 2023 owing to the availability of specialized wound care facilities and advanced treatment, and highly skilled professionals. This segment is further benefiting from the advancing numbers of diabetic foot complications among hospital admissions, along with government reimbursement programs and healthcare initiatives.
Need Any Customization Research on Diabetic Ulcer Treatment Market, Enquire Now: https://www.snsinsider.com/enquiry/3439
Regional Insights:
North America held the largest market share around 48% in 2023 due to the high prevalence of diabetes, well-developed healthcare infrastructure, and high government funds for advanced wound care treatment. Solid reimbursement policies are additionally in place in the region as well, which motivate access to higher-level therapy like NPWT, biologics and also, and skin substitutes.
Asia Pacific held a significant market share in 2023. It is due to the rapidly increasing diabetic population, surge in healthcare investments, and growing awareness about advanced wound care treatments. Asia Pacific nations are undergoing health system reforms, expanding insurance coverage, and investing in studies of means for treating wounds and getting access to treatment.
Recent Developments:
- In April 2024, The U.K. National Institute for Health and Care Excellence (NICE) evaluated Smith & Nephew’s PICO Single Use Negative Pressure Wound Therapy System (sNPWT) and concluded that it delivers improved clinical outcomes compared to standard dressings by lowering the risk of surgical site infections.
- In April 2023, 3M obtained U.S. FDA approval for two advanced products—3M Veraflo Therapy, which includes the 3M Veraflo Cleanse Choice Complete Dressing and the 3M V.A.C. Veraflo Cleanse Choice Dressing. These approvals are intended to enhance 3M’s wound care portfolio.
Exclusive Sections of the Report:
- ADOPTION RATE INSIGHTS – helps you understand the current penetration of advanced diabetic ulcer treatment solutions in 2023, highlighting the shift toward modern wound-care technologies and evidence-based treatment protocols across healthcare settings.
- USER DEMOGRAPHIC TRENDS – helps you assess usage patterns across different user groups such as clinicians, wound-care specialists, nurses, and home-care providers, enabling a clearer understanding of adoption roles and treatment responsibilities.
- FEATURE EFFECTIVENESS ANALYSIS – helps you identify which treatment features and wound-care capabilities are most preferred, such as tissue regeneration support, moisture control technologies, infection monitoring, and advanced dressing functions.
- COST STRUCTURE AND PRICING ASSESSMENT – helps you evaluate treatment affordability by analyzing the cost variations across different diabetic ulcer treatment solutions, enabling better financial planning for providers and patients.
- SYSTEM INTEGRATION CAPABILITIES – helps you uncover opportunities for enhanced patient management through solutions that integrate with EHR platforms, remote monitoring tools, and wound-tracking software to streamline care delivery.
- REGULATORY COMPLIANCE OVERVIEW – helps you understand the adherence of treatment products and digital wound-care systems to healthcare regulations and safety standards, ensuring alignment with clinical best practices in 2023.
Buy the Diabetic Ulcer Treatment Market Report Now: https://www.snsinsider.com/checkout/3439
Diabetic Ulcer Treatment Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | USD 8.22 Billion |
| Market Size by 2032 | USD 14.35 Billion |
| CAGR | CAGR of 7.21 % From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Segments | • By Type (Mouth Ulcer, Foot Ulcer)
• By Treatment (Wound Care Devices, Wound Care Dressings, Active Therapies) • By End-User (Ambulatory Surgical Centers, Hospitals and clinics, Research Organizations and Academic) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
Access Complete Report Details of Diabetic Ulcer Treatment Market Analysis & Outlook: https://www.snsinsider.com/reports/diabetic-ulcer-treatment-market-3439
[For more information or need any customization research mail us at info@snsinsider.com]
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.